UK Court Shutters Merck's Cosopt Patent Fight
The London-based Court of Appeal said in an opinion published Friday that the Chancery Division of the Patents Court had correctly ruled that Merck's patent was “invalid for want of novelty” and that it “lacked an inventive step.”
Merck was granted a European patent on Cosopt in April...
Already a subscriber? Click here to login